Jyseleca 200 mg film-coated tablets clinical trials
3 indexed studies · 0 currently recruiting
- Ongoing, recruitingTherapeutic confirmatory (Phase III)
A Multicenter, Open-label, Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Subjects with Rheumatoid Arthritis
This study is looking at the long-term safety and effectiveness of a medicine called Jyseleca for people with rheumatoid arthritis. Participants will take Jyseleca tablets, and doctors will monitor their health carefully over time.
For: Rheumatoid arthritisBulgaria · Hungary · Germany - AuthorisedTherapeutic use (Phase IV)
Filgotinib bridging in newly diagnosed rheumatoid arthritis patients (FAST RA trial); A pragmatic randomized controlled non-inferiority low intervention clinical trial
This study is testing different treatments for new rheumatoid arthritis to see which works best at getting people into remission quickly. It compares a steroid injection (Kenacort-A) with a newer tablet (Jyseleca) to find out how many people feel much better after three months.
For: Rheumatoid arthritisNetherlands - AuthorisedTherapeutic use (Phase IV)
The effect of Janus Kinase inhibitors on the heart in Rheumatoid Arthrtis
This study looks at how a medicine called Jyseleca (filgotinib) affects the heart in people with Rheumatoid Arthritis (RA) who haven't had heart problems before. Researchers will check heart function before and after one year of treatment to see if the medicine changes it.
For: Diagnosis of RA according to the ACR/EULAR 2010 criteria without a history of cardiovascular diseases · Rheumatroid ArthritisNetherlands